Navigation Links
Wysebridge Patent Bar Review Supports the National Foundation for Celiac Awareness (NFCA) During Celiac Awareness Month
Date:5/10/2013

Philadelphia, PA (PRWEB) May 10, 2013

Wysebridge Patent Bar Review, a Philadelphia based company paving the way for online Patent Bar Exam study resources and materials, is proud to announce it's support of the National Foundation for Celiac Awareness (NFCA), headquartered in Ambler, PA. For every new Wysebridge PRO membership subscription during the month of May, Wysebridge will make a donation to the NFCA. This is the first year the company is supporting the foundation, in support of Celiac Awareness Month.

In addition, Wysebridge Patent Bar Review is kicking off a social media campaign to help raise awareness of the organization and its mission in helping those already diagnosed with Celiac Disease, and also raising awareness to diagnose and treat those who are currently undiagnosed.

From the NFCA mission statement: "Awareness brings treatment that, in turn, brings improvement of the quality of life for those with celiac disease and non-celiac gluten sensitivity. Our goal is to reduce the time to diagnosis and, in the process, reduce the devastating impact of undiagnosed celiac disease, including the contraction of others diseases such as cancer, diabetes, osteoporosis, and an “autoimmune cascade."

The NFCA was founded by Alice Bast, who went many years before being diagnosed with the disease. Her desire to spare other families from needless heartache and suffering compelled her to establish the National Foundation for Celiac Awareness (NFCA) in 2003. Under Bast’s direction, the fledgling foundation quickly spread its wings, participating in the first-ever National Institutes of Health (NIH)’s Consensus Development Conference on Celiac Disease.

“By partnering and supporting the NFCA, we know that every cent donated is going directly to life-enhancing programs that support and bring healing to individuals and families that have Celiac Disease and Gluten-Sensitivities,” says Bryan Doreian, President of Wysebridge Patent Bar Review

Wysebridge Patent Bar Review is extremely excited to dedicate this month to honoring such a worth-while cause and organization.

You can follow Wysebridge Patent Bar Review using a variety of social media sites, including Twitter, Facebook, and LinkedIn Stay updated on the latest tips, study suggestions, exam changes, and intellectual property updates.

About Wysebridge Patent Bar Review
Wysebridge Patent Bar Review is an information and educational company formed in 2012 dedicated to assisting individuals study for and pass the patent bar exam.

Read the full story at http://www.prweb.com/releases/NFCA/CeliacAwareness/prweb10718242.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Wysebridge Launches Patent Bar Exam Study Review
2. Growing Job-Market Niche Inside The Economic Decline: A Wysebridge Review
3. The Fiscal Cliff Package: Wysebridge Offers Discounts
4. Wysebridge Encourages Taking The Patent Bar Before Major Exam Changes Are Implemented
5. The 2013 CES: Patents, Legislation Reform, and the Growing Market for Patent Attorneys and Agents Reviewed by Wysebridge
6. Wysebridge Patent Bar Review Announces the Launch of News Blog
7. Wysebridge Patent Bar Review Discusses Major Changes To The Patent Bar Exam
8. Wysebridge Reports 94% Success Rate for Passing the Patent Bar Exam
9. Soaring School Costs and Vanishing Jobs Demands More From Lawyers; Wysebridge Suggests Becoming a Registered Patent Attorney
10. Up to the Challenge: Careers in Science in the Midst of Drastic Change, According to Wysebridge Patent Bar Review
11. United States Patent and Trademark Office to Require Signed NDA Affects Many Reports Wysebridge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)...  BioPharmX Corporation (NYSE MKT: BPMX), a specialty ... today reported financial results for the quarter and ... an update on the company,s clinical development efforts ... are pleased to report that last year was ... Anja Krammer. "We achieved key clinical milestones and ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/23/2017)... , March 23, 2017 ... at four equities in the Biotech industry: Sangamo Therapeutics ... Biologics Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. ... st , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology ... downloading their free report at: ...
Breaking Biology Technology:
(Date:2/28/2017)... BARCELONA , Spanien, 27. Februar 2017 /PRNewswire/ ... durch Iris-Scan, wird seine erstklassige biometrische Lösung ... Snapdragon™ 835 mit X16 LTE auf dem ... 2. März) am Qualcomm-Stand in Halle 3, ... 835-Prozessor beinhaltet die Sicherheitsplattform Qualcomm Haven™ – ...
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. 22, ... Avamere Family of Companies (Avamere Health Services, Infinity Rehab, ... six-month research study that will apply the power of ... senior living and health centers. By analyzing data streaming ... gain insights into physical and environmental conditions, and obtain ...
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
Breaking Biology News(10 mins):